Never miss an update from Palatin Technologies. Did you know that during reporting season, the announcements from NYSEMKT:PTN often move the market?
|52w High/Low:||$0.66 - 1.78|
|Volume/Average:||671K - 1.2M|
A high-profile analyst questioned the company's recent FDA approval.3 Drug Stocks That Could Win From Key FDA Approvals in June
Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript
PTN earnings call for the period ending March 31, 2019.